• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

髋膝关节手术中的药物性血栓预防:新西兰骨科医生的一项调查

Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons.

作者信息

Rodgers A, Gray H, MacMahon S

机构信息

Department of Medicine, University of Auckland, New Zealand.

出版信息

Aust N Z J Surg. 1994 Mar;64(3):167-72. doi: 10.1111/j.1445-2197.1994.tb02170.x.

DOI:10.1111/j.1445-2197.1994.tb02170.x
PMID:8117192
Abstract

A survey was conducted of the attitudes and practices of New Zealand orthopaedic surgeons on the use of pharmacological thromboprophylaxis (PT) for patients undergoing major hip or knee surgery. A questionnaire was sent to all 106 consultant surgeons known to perform hip or knee surgery and a response rate of 89% was obtained. The results suggested that while almost all surgeons used PT at some time, only about one-third of elective surgery patients and just a few per cent of patients with neck of femur fracture (NOFF) receive PT. For about three-quarters of surgeons, heparin (usually low molecular weight) was the most frequently used PT. About half of the surgeons began prophylaxis pre-operatively and about half stopped it when the patients were mobile postoperatively. Previous venous thromboembolism was felt by almost all surgeons to be a very important indication for PT; gross obesity, prolonged pre-operative immobility and active malignancy were thought to be very important factors by approximately one-half of the surgeons. The presence of a major bleeding diathesis or active peptic ulcer was cited as a contraindication to PT by more than two-thirds of all surgeons. Fear of bleeding complications and the rarity of thromboembolic complications were cited as reasons for limited use of PT by about one-third of surgeons. The results suggest that most surgeons usually rely on non-pharmacological methods of thromboprophylaxis, particularly for NOFF patients.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

针对新西兰骨科医生对接受髋关节或膝关节大手术患者使用药物性血栓预防(PT)的态度和做法开展了一项调查。向所有已知进行髋关节或膝关节手术的106名顾问外科医生发送了问卷,回收率为89%。结果表明,虽然几乎所有外科医生在某些时候都会使用PT,但只有约三分之一的择期手术患者以及仅百分之几的股骨颈骨折(NOFF)患者接受PT。对于约四分之三的外科医生来说,肝素(通常是低分子量肝素)是最常用的PT。约一半的外科医生在术前开始预防,约一半在患者术后能够活动时停止预防。几乎所有外科医生都认为既往静脉血栓栓塞是PT的一个非常重要的指征;约一半的外科医生认为严重肥胖、术前长期制动和活动性恶性肿瘤是非常重要的因素。超过三分之二的外科医生将存在严重出血素质或活动性消化性溃疡列为PT的禁忌证。约三分之一的外科医生将担心出血并发症以及血栓栓塞并发症罕见作为PT使用受限的原因。结果表明,大多数外科医生通常依赖非药物性血栓预防方法,尤其是对于NOFF患者。(摘要截取自250字)

相似文献

1
Pharmacological thromboprophylaxis in hip and knee surgery: a survey of New Zealand orthopaedic surgeons.髋膝关节手术中的药物性血栓预防:新西兰骨科医生的一项调查
Aust N Z J Surg. 1994 Mar;64(3):167-72. doi: 10.1111/j.1445-2197.1994.tb02170.x.
2
Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand.
ANZ J Surg. 2002 May;72(5):335-8. doi: 10.1046/j.1445-2197.2002.02404.x.
3
Low-dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures.低剂量肝素用于全髋关节置换术和髋部骨折手术修复中预防静脉血栓栓塞。
J Bone Joint Surg Am. 1978 Dec;60(8):1065-70.
4
The Australian arthroplasty thromboprophylaxis survey.澳大利亚关节置换术血栓预防调查。
J Arthroplasty. 2012 Feb;27(2):173-9. doi: 10.1016/j.arth.2011.05.003. Epub 2011 Jul 12.
5
Venous thromboembolism prophylaxis after total hip or knee arthroplasty: a survey of Canadian orthopedic surgeons.全髋关节或膝关节置换术后的静脉血栓栓塞预防:对加拿大骨科医生的一项调查
Can J Surg. 1999 Dec;42(6):457-61.
6
A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.择期全髋关节置换术后血栓栓塞预防的荟萃分析。
J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38. doi: 10.2106/00004623-200007000-00004.
7
Low-molecular-weight heparins in orthopaedic surgery.低分子量肝素在骨科手术中的应用
Drug Ther Bull. 1993 May 10;31(10):37-8.
8
Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery: current status and perspectives.择期髋关节手术中使用肝素和低分子肝素进行血栓预防:现状与展望。
Semin Thromb Hemost. 1991 Oct;17(4):336-42. doi: 10.1055/s-2007-1002631.
9
Thromboprophylaxis practice patterns in two Western Australian teaching hospitals.西澳大利亚州两家教学医院的血栓预防实践模式
Haematologica. 2004 May;89(5):586-93.
10
Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.美国骨科外科委员会第二部分候选人报告的初次髋关节和膝关节置换术的静脉血栓栓塞预防策略的使用模式、疗效和并发症。
J Arthroplasty. 2019 Apr;34(4):729-734. doi: 10.1016/j.arth.2018.12.015. Epub 2018 Dec 22.

引用本文的文献

1
Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures.肝素、低分子量肝素及预防髋部骨折手术后深静脉血栓形成和肺栓塞的物理方法。
Cochrane Database Syst Rev. 2000;2002(2):CD000305. doi: 10.1002/14651858.CD000305.
2
Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.抗血小板治疗用于血栓预防:需要仔细考量随机试验的证据。抗血小板试验协作组。
BMJ. 1994 Nov 5;309(6963):1215-7. doi: 10.1136/bmj.309.6963.1215.